Avanos Medical (NYSE:AVNS) issued an update on its FY 2019 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $1.15-1.25 for the period, compared to the Thomson Reuters consensus estimate of $1.23. The company issued revenue guidance of $704.484-717.53 million, compared to the consensus revenue estimate of $694.54 million.Avanos Medical also updated its FY19 guidance to $1.15-1.25 EPS.
Shares of AVNS traded down $0.64 during mid-day trading on Wednesday, reaching $36.59. 647,611 shares of the company’s stock were exchanged, compared to its average volume of 329,027. The company has a debt-to-equity ratio of 0.24, a quick ratio of 2.22 and a current ratio of 2.77. The stock’s 50-day simple moving average is $42.03. Avanos Medical has a 52-week low of $35.21 and a 52-week high of $72.96. The company has a market cap of $1.82 billion, a P/E ratio of 44.62 and a beta of 1.46.
Avanos Medical (NYSE:AVNS) last issued its quarterly earnings data on Tuesday, August 6th. The company reported $0.28 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.25 by $0.03. Avanos Medical had a net margin of 2.58% and a return on equity of 4.92%. The business had revenue of $172.20 million during the quarter, compared to analysts’ expectations of $172.02 million. During the same period last year, the company posted $0.20 EPS. The company’s revenue was up 7.0% on a year-over-year basis. On average, equities research analysts predict that Avanos Medical will post 1.24 EPS for the current fiscal year.
In other news, CEO Joseph Fralin Woody bought 3,500 shares of the stock in a transaction on Thursday, May 30th. The stock was purchased at an average cost of $39.95 per share, with a total value of $139,825.00. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 1.57% of the stock is currently owned by insiders.
About Avanos Medical
Avanos Medical, Inc operates as a medical technology company that focuses on delivering medical device solutions to improve patients' quality of life worldwide. It provides a portfolio of products focuses on respiratory and digestive health; pain management solutions; and minimally invasive interventional pain therapies, closed airway suction systems, and enteral feeding tubes.
Featured Story: What is a good rate of return for a mutual fund?
Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.